Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 01-27-2008, 06:05 AM #12
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
Default a repeat !

I put Cogane on My Google alert to keep this channel of hope flowing
The following story is a repeat but it is well written as I think

Back to the Fucshia as Fox backs plant bio
Written by Sam Fountain
Wednesday, 23 January 2008
A potential Parkinson’s disease treatment developed by Phytopharm, the Cambridge company that uses medicinal plants to develop drugs, has attracted a $1.16m grant from Hollywood A-lister, Michael J Fox to further research into the firm’s medicine, Cogane.
Fox, who starred in the iconic ‘Back to the Future’ movies, was diagnosed with Parkinson's disease in 1991.

In pre-clinical models, Phytopharm’s treatment has been found to reverse changes in the area of the brain involved in Parkinson’s by inducing the body’s own production of proteins known as neurotrophic factors, in particular GDNF.

GDNF has been shown to be particularly effective in re-growing damaged nerves, but as it is a protein can’t be administered orally and struggles to cross the blood-brain barrier.

GDNF can work only when injected into or when produced inside the brain, and direct injection of GDNF into the area of the brain involved in Parkinson’s has shown substantial beneficial effects in small-scale clinical studies but requires highly complex and difficult surgical procedures.

Cogane, which can be taken orally, readily crosses the blood-brain barrier and stimulates the release of GDNF in the brain.

The award comes from The Michael J. Fox Foundation (MJFF) set up in 2000 by Fox, who famously hid his suffering from the debilitative disease for a number of years whilst continuing to act on television.

“MJFF is extremely eager to see the development of an orally bioavailable product that can stimulate production of GDNF or other neurotrophic factors in the brain,” said CEO of the foundation, Katie Hood.

“The development of novel alternative delivery mechanisms for neurotrophic factors is critical in realising the potential of these proteins to restore motor function and increase quality of life for Parkinson’s disease patients.”

Parkinson’s disease is a movement disorder caused by altered signalling of an area of the brain, and resulting in muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement.
__________________
Imad
Born in 1943. Diagnosed with PD in 2006.
imark3000 is offline   Reply With QuoteReply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Cogane Suffolkchris Parkinson's Disease 15 10-04-2010 01:11 AM
Cogane paula_w Parkinson's Disease Clinical Trials 1 06-11-2007 02:46 AM
Cogane Data presented at Movement Disorders Congress jeanb Parkinson's Disease 3 06-07-2007 07:47 PM
I Remember You Alffe Coping with Grief & Loss 0 03-16-2007 07:29 AM
Remember when??? Abbie On the Lighter Side 2 02-22-2007 09:02 AM


All times are GMT -5. The time now is 02:12 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.